PUBLISHER: Euromonitor International | PRODUCT CODE: 1561928
PUBLISHER: Euromonitor International | PRODUCT CODE: 1561928
Analgesics in Italy
Analgesics is set to see a decline in retail value sales in current terms in Italy in 2024. The category's performance was adversely affected by a peculiar flu season. Despite the record 14.5 million infections reported by RespiVirNet, the flu season showed an unusual pattern. In fact, the high number of infections was contrasted by a rather narrow time frame, with the peak concentrated at the end of December 2023. This led to a drop in analgesics sales as early as the second week of January. Th...
Euromonitor International's Analgesics in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
TABLE OF CONTENTS
List Of Contents And Tables
KEY DATA FINDINGS
2024 DEVELOPMENTS
- Unexpectedly short flu season stalls analgesics sales
- Ibuprofen's broad appeal fuels growth despite unusual flu season driven by quick release formulations
- Topical analgesics/anaesthetic continues to suffer from the poor performance of patches and competition from non-medicated options.
PROSPECTS AND OPPORTUNITIES
- Chronic pain treatment as an opportunity for analgesics despite competition from non-pharmacological alternatives
- Women's health focus to drive growth for specifically targeted analgesics
- Topical analgesics/anaesthetic category to shift to more comfortable formats and better user experience
CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2019-2024
- Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN ITALY
EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
DISCLAIMER
DEFINITIONS
SOURCES
- Summary 1 Research Sources
